GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,120 | -4.2% | 30,156 | +38.1% | 0.00% | 0.0% |
Q2 2023 | $26,211 | +22495.7% | 21,843 | -76.4% | 0.00% | -75.0% |
Q1 2023 | $116 | -22.1% | 92,436 | +34.2% | 0.00% | -33.3% |
Q4 2022 | $149 | -99.9% | 68,888 | +336.3% | 0.01% | +100.0% |
Q3 2022 | $189,000 | +656.0% | 15,788 | +437.7% | 0.00% | +200.0% |
Q2 2022 | $25,000 | -64.8% | 2,936 | -64.4% | 0.00% | 0.0% |
Q1 2022 | $71,000 | +121.9% | 8,251 | +189.4% | 0.00% | 0.0% |
Q4 2021 | $32,000 | -66.0% | 2,851 | -62.0% | 0.00% | -50.0% |
Q3 2021 | $94,000 | +30.6% | 7,498 | -16.1% | 0.00% | 0.0% |
Q2 2021 | $72,000 | +242.9% | 8,932 | +293.5% | 0.00% | – |
Q1 2021 | $21,000 | -44.7% | 2,270 | -42.6% | 0.00% | -100.0% |
Q4 2020 | $38,000 | +35.7% | 3,958 | +77.3% | 0.00% | – |
Q3 2020 | $28,000 | -72.5% | 2,232 | -71.5% | 0.00% | -100.0% |
Q2 2020 | $102,000 | +277.8% | 7,819 | +357.8% | 0.00% | +100.0% |
Q4 2019 | $27,000 | -88.7% | 1,708 | -88.0% | 0.00% | -87.5% |
Q3 2019 | $239,000 | +7866.7% | 14,262 | +11986.4% | 0.02% | – |
Q1 2019 | $3,000 | – | 118 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |